NKTR-214 (Cohort A)
PICI0033
Phase 1 small_molecule completed
Quick answer
NKTR-214 (Cohort A) for Metastatic Castration-resistant Prostate Cancer is a Phase 1 program (small_molecule) at INOVIO PHARMACEUTICALS, INC. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- INOVIO PHARMACEUTICALS, INC.
- Indication
- Metastatic Castration-resistant Prostate Cancer
- Phase
- Phase 1
- Modality
- small_molecule
- Status
- completed